tirzepatide heart failure trial Effects of on the Clinical Trajectory of Patients With Failure, Preserved Ejection Fraction, and Obesity SUMMIT: Tirzepatide a 'Huge Win'
Description
Together, these changes may eventually lead to myocardial fibrosis and systolic dysfunction
Reviewed by Brian Ranger Wilson, Esquire Last update: June 3, 2026 Est
Our team will review your health history and determine whether treatment is appropriate
Cardiovascular Outcomes Things get even more interesting when looking at this marker of metabolic health
